Challenges in launching multinational oncology clinical trials in India

Challenges in launching multinational oncology clinical trials in India

In the recent past, there has been an impressive growth in the number of clinical trials launched worldwide, including India. Participation in well-designed oncology clinical trials is of advantage to Indian healthcare system in general, and cancer patients in particular. However, the number of clin...

Full description

Bibliographic Details
Main Authors: Kamal S Saini, Gaurav Agarwal, Ramesh Jagannathan, Otto Metzger-Filho, Monika L Saini, Khurshid Mistry, Raghib Ali, Sudeep Gupta
Format: Article
Language:English
Published: Thieme Medical and Scientific Publishers Pvt. Ltd. 2013-01-01
Series:South Asian Journal of Cancer
Subjects:
Cancer
challenges
clinical trials
delays
India
obstacles
oncology
regulatory
research
South Asia
Online Access:http://journal.sajc.org/article.asp?issn=2278-330X;year=2013;volume=2;issue=1;spage=44;epage=49;aulast=Saini
Description
Summary:In the recent past, there has been an impressive growth in the number of clinical trials launched worldwide, including India. Participation in well-designed oncology clinical trials is of advantage to Indian healthcare system in general, and cancer patients in particular. However, the number of clinical trials being run in India is not commensurate with the cancer burden prevailing in the country. In this article, the authors investigate the reasons for this discrepancy, highlight critical bottlenecks, and propose ways to ameliorate the situation.
ISSN:2278-330X
2278-4306

Similar Items